Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)

Autor: J. Van Wyk, F. Ajana, F. Bisshop, S. De Wit, Y. Osiyemi, J. Portilla, J. Routy, C. Wyen, M. Ait-Khaled, M. Nascimento, K. Pappa, R. Wang, J. Wright, A. Tenorio, B. Wynne, M. Aboud, M. Gartland, K. Smith, Y. El-Bahy
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Journal of Infection and Public Health, Vol 13, Iss 2, Pp 349- (2020)
Druh dokumentu: article
ISSN: 1876-0341
DOI: 10.1016/j.jiph.2020.01.117
Databáze: Directory of Open Access Journals